News

The Pharma Letter6h
Biocon Biologics receives MHRA approval for Yesintek
Indian biosimilars developer Biocon Biologics, a subsidiary of Biocon Ltd (BSE: 532520, today announced that the UK’s ...
The Pharma Letter4h
Zuellig Pharma launches Lilly’s Mounjaro in Thailand
Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...
Montreal Gazette on MSN7h
Explainer: How does Quebec’s new French signage law work and what are the non-compliance penalties?
Roberge once estimated the total cost for Quebec retailers to comply would range from $7 million to $15 million. That ...